All Stories

  1. Film Coating of Small Molded Tablets for Pediatric Formulations with Rapid Disintegration and Bitterness-Masking Properties
  2. Granulation Methods and the Mechanisms for Improving Hardness of Loxoprofen Sodium Hydrate-Containing Tablets
  3. Evaluating Various Lactose Types as Solid Carriers for Improving Curcumin Solubility in Solid Self-Nanoemulsifying Drug Delivery Systems (S-SNEDDSs) for Oral Administration
  4. Characterization and Crystal Structural Analysis of Novel Carvedilol Adipate and Succinate Ethanol-Solvated Salts
  5. Fabrication and Characterization of Pectin Films Containing Solid Lipid Nanoparticles for Buccal Delivery of Fluconazole
  6. Crystal Polymorph Search in the NPT Ensemble via a Deposition/Sublimation Alchemical Path
  7. Prediction of Binding Pose and Affinity of Nelfinavir, a SARS-CoV-2 Main Protease Repositioned Drug, by Combining Docking, Molecular Dynamics, and Fragment Molecular Orbital Calculations
  8. The Development and Characterization of Novel Ionic Liquids Based on Mono- and Dicarboxylates with Meglumine for Drug Solubilizers and Skin Permeation Enhancers
  9. The Effect of Cholesterol Content on the Adjuvant Activity of Nucleic-Acid-Free Lipid Nanoparticles
  10. Novel method for the accurate calculation of Drucker–Prager cap model parameters and reduction of experimental time and effort
  11. Characterization of co-amorphous carvedilol–maleic acid system prepared by solvent evaporation
  12. Physicochemical Properties and Transdermal Absorption of a Flurbiprofen and Lidocaine Complex in the Non-Crystalline Form
  13. Swelling and Salt Formation in Ibuprofen and Tranexamic Acid-Containing Tablets during High-Temperature Storage
  14. Study of Orally Disintegrating Tablets Using Erythritol as an Excipient Produced by Moisture-Activated Dry Granulation (MADG)
  15. Non-Effective Improvement of Absorption for Some Nanoparticle Formulations Explained by Permeability under Non-Sink Conditions
  16. Crystal Structures of Antiarrhythmic Drug Disopyramide and Its Salt with Phthalic Acid
  17. Crystal Structure of Novel Terephthalate Salt of Antiarrhythmic Drug Disopyramide
  18. Dose-Dependent Solubility–Permeability Interplay for Poorly Soluble Drugs under Non-Sink Conditions
  19. Miscibility characterization of zein/methacrylic acid copolymer composite films and plasticization effects
  20. Cholesteryl-Conjugated Ribonuclease A Exhibits Enzyme Activity in Aqueous Solution and Resistance to Dimethyl Sulfoxide
  21. Synthesis and Characterization of Cholesteryl Conjugated Lysozyme (CHLysozyme)
  22. Application of void forming index (VFI): Detection of the effect of physical properties of dry powder inhaler formulations on powder cohesion
  23. Tablet Quality-Prediction Model Using Quality Material Attributes: Toward Flexible Switching Between Batch and Continuous Granulation
  24. Effect of Polymers and Storage Relative Humidity on Amorphous Rebamipide and Its Solid Dispersion Transformation: Multiple Spectra Chemometrics of Powder X-Ray Diffraction and Near-Infrared Spectroscopy
  25. Prediction of the Crystal Growth Mechanism of Aspirin Using Molecular Simulations
  26. Self‐Degradable Lipid‐Like Materials Based on “Hydrolysis accelerated by the intra‐Particle Enrichment of Reactant (HyPER)” for Messenger RNA Delivery
  27. Novel approach to evaluating granulation and segregation level considering the contribution of hydroxypropyl cellulose to the surface property change of granules
  28. Evaluation of the physical properties of dry surface-modified ibuprofen using a powder rheometer (FT4) and analysis of the influence of pharmaceutical additives on improvement of the powder flowability
  29. Degradation Pathway of a Taxane Derivative DS80100717 Drug Substance and Drug Product
  30. New approach to optimizing risk management of the sticking problem using scale-independent critical material attributes and the quantitative process parameter
  31. Preface of the Special Issue “Pharmaceutical Crystals”
  32. Crystal Structural Analysis of DL-Mandelate Salt of Carvedilol and Its Correlation with Physicochemical Properties
  33. Structural origin of physicochemical properties differences upon dehydration and polymorphic transformation of ciprofloxacin hydrochloride revealed by structure determination from powder X-ray diffraction data
  34. Formulation design and evaluation of a transdermal drug delivery system containing a novel eptazocine salt with the Eudragit® E adhesive
  35. Examples of Clinical Formulation Design at a University and Response to Clinical Need
  36. Importance of free water in controlling granule and tablet properties in a novel granulation method, green fluidized bed granulation (GFBG)
  37. A New Method for Classification of Salts and Cocrystals Using Solid-State UV Spectrophotometry
  38. Foreword
  39. Development of microparticles coated with poly-γ-glutamic acid to improve oral absorption of a poorly water-soluble drug
  40. Capturing a new hydrate polymorph of amodiaquine dihydrochloride dihydrateviaheterogeneous crystallisation
  41. Novel, Lean and Environment-friendly Granulation Method: Green Fluidized Bed Granulation (GFBG)
  42. Effect of sulfobutyl ether-β-cyclodextrin and propylene glycol alginate on the solubility of clozapine
  43. How Can the Researchers in University Be Involved with the Stream of Hospital Preparations from the Medical Needs to the Clinical Application?
  44. Solubility Improvement of Benexate through Salt Formation Using Artificial Sweetener
  45. Improvement of tabletability desloratadine
  46. Ethyl Haematommate fromStereocaulon graminosumSchaer.: Isolation and Crystal Structure
  47. Simultaneous Improvement of Epalrestat Photostability and Solubility via Cocrystallization: A Case Study
  48. Void forming index: A new parameter for detecting microstructural transformation caused by powder agglomeration
  49. Enhanced dissolution and skin permeation profiles of epalrestat with β-cyclodextrin derivatives using a cogrinding method
  50. A new solvate of epalerstat, a drug for diabetic neuropathy
  51. Epalrestat tetrahydrofuran monosolvate: crystal structure and phase transition
  52. Molecular Dynamics of Amorphous Sulfamethazine With Structurally Related Sulfonamide Impurities Evaluated Using Thermal Analysis
  53. Mechanisms for Improved Hygroscopicity of L-Arginine Valproate Revealed by X-Ray Single Crystal Structure Analysis
  54. Characterization of complexes between phenethylamine enantiomers and β-cyclodextrin derivatives by capillary electrophoresis-Determination of binding constants and complex mobilities
  55. Solubility improvement of epalrestat by layered structure formation via cocrystallization
  56. Effect of Magnesium Stearate Mono- and Dihydrate Dispersibilities on Physical Properties of Tablets
  57. The effect of structurally related impurities on crystallinity reduction of sulfamethazine by grinding
  58. Crystallographic Analysis of Phase Dissociation Related to Anomalous Solubility of Irsogladine Maleate
  59. Isostructural Multicomponent Gliclazide Crystals with Improved Solubility
  60. Crystal Structure Determination of Dimenhydrinate after More than 60 Years: Solving Salt–Cocrystal Ambiguity via Solid-State Characterizations and Solubility Study
  61. Drug–Drug Multicomponent Crystals as an Effective Technique to Overcome Weaknesses in Parent Drugs
  62. The effect of water activity on granule characteristics and tablet properties produced by moisture activated dry granulation (MADG)
  63. Tumor delivery of liposomal doxorubicin prepared with poly-L-glutamic acid as a drug-trapping agent
  64. General understanding on physical stability of pharmaceutical glasses
  65. Characterization and Quality Control of Pharmaceutical Cocrystals
  66. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes
  67. Triboelectrification of active pharmaceutical ingredients: week acids and their salts
  68. Therapeutic effect for liver-metastasized tumor by sequential intravenous injection of anionic polymer and cationic lipoplex of siRNA
  69. Physicochemical and crystal structure analysis of pranlukast pseudo-polymorphs II: Solvate and cocrystal
  70. Zoledronic acid enhances antitumor efficacy of liposomal doxorubicin
  71. Correlation between Glass-Forming Ability and Fragility of Pharmaceutical Compounds
  72. Physicochemical and crystal structure analysis of pranlukast pseudo-polymorphs I: Anhydrates and hydrate
  73. The importance of binder moisture content in Metformin HCL high-dose formulations prepared by moist aqueous granulation (MAG)
  74. Sequential intravenous injection of anionic polymer and cationic lipoplex of siRNA could effectively deliver siRNA to the liver
  75. Evaluation of antitumor effect of zoledronic acid entrapped in folate-linked liposome for targeting to tumor-associated macrophages
  76. Effects of Formulation and Process Factors on the Crystal Structure of Freeze-Dried Myo-Inositol
  77. Studying the Morphology of Lyophilized Protein Solids Using X-ray Micro-CT: Effect of Post-freeze Annealing and Controlled Nucleation
  78. Relationship between Crystallization Tendencies during Cooling from Melt and Isothermal Storage: Toward a General Understanding of Physical Stability of Pharmaceutical Glasses
  79. Low-Density Microparticles with Petaloid Surface Structure for Pulmonary Drug Delivery
  80. Clarifying the mechanism of aggregation of particles in high-shear granulation based on their surface properties by using micro-spectroscopy
  81. In vivo siRNA delivery system for targeting to the liver by poly-l-glutamic acid-coated lipoplex
  82. Optimization of Primary Drying Condition for Pharmaceutical Lyophilization Using a Novel Simulation Program with a Predictive Model for Dry Layer Resistance
  83. Importance of excipient wettability on tablet characteristics prepared by moisture activated dry granulation (MADG)
  84. Determination for dry layer resistance of sucrose under various primary drying conditions using a novel simulation program for designing pharmaceutical lyophilization cycle
  85. Polymorphic and pseudomorphic transformation behavior of acyclovir based on thermodynamics and crystallography
  86. Evaluation of physicochemical properties on the blending process of pharmaceutical granules with magnesium stearate by thermal effusivity sensor
  87. Evaluation of the crystalline and amorphous states of drug products by nanothermal analysis and Raman imaging
  88. Diffusivity of amorphous drug in solid dispersion
  89. Competition of Thermodynamic and Dynamic Factors During Formation of Multicomponent Particles via Spray Drying
  90. Practical Approach for Measuring Heat Capacity of Pharmaceutical Crystals/Glasses by Modulated-Temperature Differential Scanning Calorimetry
  91. Mechanism of Dehydration–Hydration Processes of Lisinopril Dihydrate Investigated by ab Initio Powder X-ray Diffraction Analysis
  92. Determination of Surface Free Energy and Contact Angle for Hydrolyzed Shellac
  93. Applying terahertz technology for nondestructive detection of crack initiation in a film-coated layer on a swelling tablet
  94. Cocrystallization and amorphization induced by drug–excipient interaction improves the physical properties of acyclovir
  95. Component Crystallization and Physical Collapse during Freeze-Drying of L-Arginine^|^#8211;Citric Acid Mixtures
  96. Potential of synchrotron X-ray powder diffractometry for detection and quantification of small amounts of crystalline drug substances in pharmaceutical tablets
  97. Process analytical technology applied for end-point detection of pharmaceutical blending by combining two calibration-free methods: Simultaneously monitoring specific near-infrared peak intensity and moving block standard deviation
  98. Swelling kinetics of spray-dried chitosan acetate assessed by magnetic resonance imaging and their relation to drug release kinetics of chitosan matrix tablets
  99. Development of a Rapid Process Monitoring Method for Dry-Coated Tableting Process by Using Near-Infrared Spectroscopy
  100. Do Amorphous Troglitazones Prepared from Two Diastereomer-Pairs Have the Same Molecular Mobility and Crystallization Rate at the Surface?
  101. Molecular States of p-Dimethylaminobenzonitrile Coground with β-Cyclodextrin Investigated Using Solid-State Fluorescence Spectroscopy
  102. Study of the Pseudo-Crystalline Transformation from Form I to Form II of Thiamine Hydrochloride (Vitamin B1)
  103. Development of a method for nondestructive NIR transmittance spectroscopic analysis of acetaminophen and caffeine anhydrate in intact bilayer tablets
  104. Effects of Solute Miscibility on the Micro- and Macroscopic Structural Integrity of Freeze-Dried Solids
  105. Investigation of the dynamic process during spray-drying to improve aerodynamic performance of inhalation particles
  106. Freeze-drying of proteins with glass-forming oligosaccharide-derived sugar alcohols
  107. Physicochemical Understanding of Polymorphism and Solid-State Dehydration/Rehydration Processes for the Pharmaceutical Material Acrinol, by Ab Initio Powder X-ray Diffraction Analysis and Other Techniques
  108. Prediction of the induction period of crystallization of naproxen in solid dispersion using differential scanning calorimetry
  109. Reevaluation of solubility of tolbutamide and polymorphic transformation from Form I to unknown crystal form
  110. Freeze-Drying of Proteins in Glass Solids Formed by Basic Amino Acids and Dicarboxylic Acids
  111. Solid States Fluorescence Study of p-Dimethylaminobenzonitrile by Co-grinding with Cyclodextrins
  112. Stabilization of Protein Structure in Freeze-Dried Amorphous Organic Acid Buffer Salts
  113. Evaluation of solid dispersions on a molecular level by the Raman mapping technique
  114. Development of a method for the determination of caffeine anhydrate in various designed intact tables by near-infrared spectroscopy: A comparison between reflectance and transmittance technique
  115. Effect of the type of lubricant on the characteristics of orally disintegrating tablets manufactured using the phase transition of sugar alcohol
  116. Applicability of DPI formulations for novel neurokinin receptor antagonist
  117. Effect of grinding on the dehydration behavior of nedocromil sodium hydrates
  118. Evaluation of dispersion state of the two racemic compounds of troglitazone in pharmaceutical granules using IR-to-THz imaging
  119. Application and Mechanism of Inhalation Profile Improvement of DPI Formulations by Mechanofusion with Magnesium Stearate
  120. Glass-State Amorphous Salt Solids Formed by Freeze-Drying of Amines and Hydroxy Carboxylic Acids: Effect of Hydrogen-Bonding and Electrostatic Interactions
  121. Effect of physical properties of troglitazone crystal on the molecular interaction with PVP during heating
  122. Application of microcalorimetry to the formulation study
  123. Estimation of physical stability of amorphous solid dispersion using differential scanning calorimetry
  124. Mechanism of glass ampoule breakage prevention during the freeze-drying process of sodium thiopental lyophilization products on addition of sodium chloride
  125. Application of XRD-DSC system to the optimization of manufacturing process for the freeze-dried pharmaceuticals
  126. Solid-state 13C NMR study of indomethacin polymorphism
  127. Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose
  128. Novel Approach to DPI Carrier Lactose with Mechanofusion Process with Additives and Evaluation by IGC
  129. Formulation design of a novel fast-disintegrating tablet
  130. Effects of water content in physical mixture and heating temperature on crystallinity of troglitazone-PVP K30 solid dispersions prepared by closed melting method
  131. Evaluation of the physical stability and local crystallization of amorphous terfenadine using XRD–DSC and micro-TA
  132. Investigation of optimal manufacturing process for freeze-dried formulations: Observation of frozen solutions by low temperature X-ray diffraction measurements
  133. Comparison of Molecular Mobility in the Glassy State Between Amorphous Indomethacin and Salicin Based on Spin-Lattice Relaxation Times
  134. Effects of sugar ester and hydroxypropyl methylcellulose on the physicochemical stability of amorphous cefditoren pivoxil in aqueous suspension
  135. Application of Eudragit RS to thermo-sensitive drug delivery systems
  136. Development of Fast Disintegrating Compressed Tablets Using Amino Acid as Disintegratation Accelerator: Evaluation of Wetting and Disintegration of Tablet on the Basis of Surface Free Energy
  137. Amorphous ultrafine particle preparation for improvement of bioavailability of insoluble drugs: grinding characteristics of fine grinding mills
  138. Change in the physicochemical properties of ursodeoxycholic acid by grinding
  139. Changes in surface properties by granulation and physicochemical stability of granulated amorphous cefditoren pivoxil with additives
  140. Physicochemical properties and surface free energy of ground talc
  141. Uniformity and physical states of troglitazone in solid dispersions determined by electron probe microanalysis and microthermal analysis
  142. Microscopic molecular mobility of amorphous AG-041R measured by solid-state 13C NMR
  143. Quantitative Determination of Amorphous Nicardipine Hydrochloride in Long Acting Formula (NIC-LA®) Using Light Anhydrous Silicic Acid
  144. Factors affecting the apparent solubility of ursodeoxycholic acid in the grinding process
  145. Solid-State Fluorescence Study of Naphthalene Adsorption on Porous Material
  146. Application of Eudragit RS to Thermo-Sensitive Drug Delivery Systems. I. Thermo-Sensitive Drug Release from Acetaminophen Matrix Tablets Consisting of Eudragit RS/PEG 400 Blend Polymers
  147. Estimation of Initial Dissolution Rate of Drug Substance by Thermal Analysis: Application for Carbamazepine Hydrate
  148. Characterization of Polymorphs of a Novel Quinolinone Derivative, TA-270 (4-Hydroxy-1-methyl-3-octyloxy-7-sinapinoylamino-2(1H)-quinolinone).
  149. Interaction of Microcrystalline Cellulose and Water in Granules Prepared by a High-Shear Mixer.
  150. Molecular Properties of Propranolol Hydrochloride Prepared as Drug-Resin Complexes
  151. Molecular States of 2-Naphthoic Acid in Solid Dispersions with Porous Crystalline Cellulose, as Investigated by Fluorescence Spectroscopy
  152. Quantitative correlation between initial dissolution rate and heat of fusion of drug substance
  153. Near IR spectroscopy to quantify the silica content and difference between silicified microcrystalline cellulose and physical mixtures of microcrystalline cellulose and silica
  154. Specific complexation of ursodeoxycholic acid with guest compounds induced by co-grinding
  155. Effect of Water-Soluble Carriers on Dissolution Characteristics of Nifedipine Solid Dispersions
  156. Molecular State of Chlorpheniramine in Resinates.
  157. Physicochemical Properties of Ursodeoxycholic Acid Dispersed in Controlled Pore Glass
  158. Water sorption and near IR spectroscopy to study the differences between microcrystalline cellulose and silicified microcrystalline cellulose before and after wet granulation
  159. Physicochemical properties of amorphous clarithromycin obtained by grinding and spray drying
  160. Fluorometric Studies of Pyrene Adsorption on Porous Crystalline Cellulose
  161. The use of near infra-red spectroscopy to detect changes in the form of amorphous and crystalline lactose
  162. Structural change and complexation of strictly linear amylose induced by sealed-heating with salicylic acid
  163. Effect of Guest Species on Inclusion Compound Formation of Deoxycholic Acid by Co-Grinding.
  164. Improved dissolution of ofloxacin via solid dispersion
  165. A 1:1 Deoxycholic Acid–Salicylic Acid Complex
  166. Enhanced Dissolution of Ursodeoxycholic Acid from the Solid Dispersion
  167. Time resolved fluorescent analysis for sealed heating of dimethyl-?-cyclodextrin and naphthalene system
  168. Freeze-drying of drug-additive binary systems. IV. Effects of saccharide addition on the crystallization of cefazolin sodium in frozen aqueous solution
  169. Thermal Behavior of Methyl p-hydroxybenzoate in Controlled-Pore Glass Solid Dispersion
  170. Dissolution studies in organic solvents for evaluating hydrogen-bond matrix of cellulose in the ground mixture
  171. Factors affecting the formation in the solid state of the metastable complex between naphthalene and dimethyl-?-cyclodextrin
  172. Peculiar Peak Shifts in the IR Spectrum of Benzoic Acid Crystals by Compression with Methylated Additives.
  173. Complex formation between naphthalene and dimethyl-β-cyclodextrin by heating in a sealed ampoule
  174. meta-Stable Complex Formation between 2,6-Di-O-methyl-,.BETA.-cyclodextrin and Naphthalene during Sealed-Heating Process.
  175. Physicochemical Properties of Amorphous Ursodeoxycholic Acid Obtained by Grinding.
  176. Acceleration of the addition reaction of succinic anhydride and p-nitroaniline in synthetic aluminium silicate
  177. Molecular States of Pyrene in the Ground Mixtures with Cyclodextrins Studied by Fluorescence Spectroscopy.
  178. Thermal behavior of ground mixtures of heptakis (2,6-di-O-methyl)-?-cyclodextrin and benzoic acid
  179. Polymorphism of Tegafur: Physico-chemical Properties of Four Polymorphs.
  180. Effect of Saccharide on the Decomposition of Cephalothin Sodium and Benzylpenicillin Potassium in Freeze-Dried Preparations.
  181. Solubility Parameter and Dissolution Behavior of Cefalexin Powders with Different Crystallinity.
  182. Diffusion and reaction of p-nitroaniline and succinic anhydride in controlled pore glass.
  183. New Methods for Preparing Cyclodextrin Inclusion Compounds. IV. Enhancement of Combining Molar Ratio by Using a Ground Mixture in Heptakis-(2,6-di-O-methyl)-.BETA.-cyclodextrin and Benzoic Acid System.
  184. Stability of aspirin in controlled pore glass solid dispersions.
  185. Freeze-drying of drug-additive binary systems III. Crystallization of α-cyclodextrin inclusion complex in freezing process
  186. Effect of grinding on dehydration of crystal water of theophylline.
  187. New methods for preparing cyclodextrin inclusion compounds. III. Preparation of heptakis-(2,6-di-O-methyl)-.BETA.-cyclodextrin-benzoic acid inclusion compound by sealed heating.
  188. Acceleration of the addition reaction of succinic anhydride and p-nitroaniline in controlled-pore glass solid dispersions.
  189. Freeze-drying of drug-additive binary systems. II. Relationship between decarboxylation behavior and molecular states of p-aminosalicylic acid.